30 June 2022

Getinge’s new DPTE®-EXO with Sleeveless DPTE-BetaBag takes aseptic transfer to a new level


Today Getinge releases the new DPTE-EXO with Sleeveless DPTE-BetaBag. It is a first of its kind alpha port with external opening and integrated funnel, securing automated aseptic transfer and improving operational efficiency for Life Science customers worldwide.

While discovering, developing and producing drugs, the pharma industry is facing increased demands on throughput and automation at the same time as GMP requirements are becoming stricter.

“As the industry evolves, the next generation of pharmaceutical manufacturing needs greater flexibility of the batch’s size to switch production quickly from one drug to another,” says Anneke Evers, Senior Director DPTE Sales & Market Support at Getinge.

Getinge’s new total solution DPTE-EXO with Sleeveless DPTE-BetaBag is an answer to customer needs, providing a secure, reliable, and automated transfer solution.

“The function with the external opening was designed to significantly reduce the risk of contamination while its connectivity offers a greater degree of traceability and data analysis. DPTE-EXO with Sleeveless DPTE-BetaBag supports the efforts to build safe, automated, and compliant filling lines.”

The motorized external opening alpha port combined with an optional funnel also provides operational efficiency by reducing manual intervention and freeing up time for the operator.

“It’s easy to use and has several smart controls governing its safe and efficient door opening and closing and funnel movements. It also integrates a specific program with an open door and funnel position suitable for the barrier system bio-decontamination cycle.”

She continues:

 “The DPTE-EXO with Sleeveless DPTE-BetaBag is a fully validated and interlocked system. Together with the dismountable funnels, it offers a total transfer solution from the outside to the process area. With this product launch, we want to be part of opening up the door to the future, supporting the exciting yet challenging pharma industry transition.”

No comments:

Post a Comment

CONTACTO · Aviso Legal · Política de Privacidad · Política de Cookies

Copyright © Noticia de Salud